Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Counterimmunoelectrophoresis in determination of prostatic acid phosphatase in human serum

Journal Article · · Clin. Chem.; (United States)
OSTI ID:5046019
 [1]; ;
  1. Southern California Permanente Medical Group, Los Angeles
We evaluated counterimmunoelectrophoresis for use in measuring prostatic acid phosphatase in detection of prostatic cancer. After staining for acid phosphatase, we could detect as little as 0.3 ng of purified enzyme standard complexed with antibody by this technique. However, when serum samples were used as antigen, the method was less sensitive (1.5-2.0 ng) because some of the serum proteins migrate with the phosphatase and decrease the intensity of the stain for acid phosphatase. For this reason we could not detect the phosphatase in serum samples of normal persons; only patients with moderately (or greater) increased activity in their serum showed positive results. In contrast, by radioimmunoassay as little as 1.0 ng of the phosphatase can be detected in serum.
OSTI ID:
5046019
Journal Information:
Clin. Chem.; (United States), Journal Name: Clin. Chem.; (United States) Vol. 24:1; ISSN CLCHA
Country of Publication:
United States
Language:
English

Similar Records

Solid-phase radioimmunoassay for human prostatic acid phosphatase
Journal Article · Mon Sep 01 00:00:00 EDT 1975 · Cancer Res., v. 35, no. 9, pp. 2446-2451 · OSTI ID:4038710

Comparison of human prostatic acid phosphatase by measurement of enzymatic activity and by radioimmunoassay
Journal Article · Fri Dec 31 23:00:00 EST 1976 · Clin. Chem.; (United States) · OSTI ID:7226295

Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase. [/sup 125/I tracer technique]
Journal Article · Wed Dec 21 23:00:00 EST 1977 · New Engl. J. Med.; (United States) · OSTI ID:5090579